Evaluation of Microinvasive Glaucoma Surgery: MINIject® Versus Hydrus® Microstent in Combination With Cataract Surgery
Recruiting · NCT06844292 · Interventional (participants receive a specific treatment) · Lead sponsor: Medical University of Graz
View the official record on ClinicalTrials.gov →Interventions studied
Hydrus Microstent with Cataract SurgeryMINIject with Cataract Surgery
What this trial is about
The study aims to investigate postoperative outcomes after two different MIGS implants (MINIject or Hydrus) in combination with cataract surgery for patients with glaucoma.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients with glaucoma in which surgery is indicated to reach target intraocular pressure as well as lens opacities where CS is indicated
- Clinically eligible for both surgeries
- Subjects not anticipated to require any further surgery in the next 12 months
- Patients' age \> 18 years
Exclusion criteria
- Patients who do not want to make follow-ups at the department
- Angle closure, uveitic, neovascular, congenital glaucoma, iridocorneal endothelial syndrome, Axenfeld-Rieger syndrome
- Prior filtering glaucoma surgery, suprachoroidal stent, retinal surgery, corneal graft surgery or cyclophotocoagulation
- Allergy to any drugs or substances required for the protocol
- Pregnant women
Where it is running
1 location listed.
- Medical University Graz - Graz, Styria, Austria